Ruthigen Establishes Independent Headquarters and Targets Public Offering In 2013
[at noodls] – PETALUMA, Calif. and SANTA ROSA, Calif., Jan. 28, 2013 (GLOBE NEWSWIRE) — Ruthigen, Inc., a biopharmaceutical company focused on a unique and new drug candidate, RUT58-60, today announced it has established … more
View todays social media effects on OCLS
View the latest stocks trending across Twitter. Click to view dashboard